GEG

MKT CAP:$57M

Great Elm Group, Inc.

Market Cap

$57M

Healthcare·Medical - Distribution·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$2.13-$0.41 (-16.14%)

Apr 23, 2026

Company Details

Great Elm Group, Inc. engages in the durable medical equipment and investment management businesses. The company distributes respiratory care equipment, including positive air pressure equipment and supplies, ventilators and oxygen equipmen...

CEO

Jason W. Reese

IPO Date

Jun 11, 1999

Website

www.greatelmgroup.com

Key Metrics TTM

Revenue

$15M

— YoY

Net Income

$719.0K

EPS (Diluted)

-$0.09

Free Cash Flow

$3M

Revenue / Share

$0.39

Gross Margin

-1.7%

Operating Margin

-64.9%

Net Margin

4.9%

FCF Margin

19.0%

P/S

3.9x

P/E

78.7x

Earnings Reports

Q1 2026

May 6, 2026

PENDING

Q4 2025

Sep 2, 2025

$6MEPS $0.36

Q3 2025

May 7, 2025

$3M+15.1%EPS -$0.17

Q3 2024

May 8, 2024

$3MEPS -$0.10

Q4 2023

Sep 20, 2023

$3MEPS -$0.18

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 16	$0	$0	-$2M
Q2 23	$2M	-$432.0K	-$3M
Q4 23	$3M	-$277.0K	-$4M
Q3 24	$3M	$54.0K	-$2M
Q3 25	$3M	-$813.0K	-$3M
Q4 25	$6M	$788.0K	-$1M

Valuation

Quarter	P/S	P/E
Q3 16	—	—
Q2 23	—	—
Q4 23	—	—
Q3 24	7.4x	5.0x
Q3 25	5.2x	3.4x
Q4 25	3.9x	78.7x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 16	-$12M	-$12M
Q2 23	-$680.0K	$2M
Q4 23	$434.0K	$418.0K
Q3 24	$1M	$0
Q3 25	-$1M	-$1M
Q4 25	$4M	$4M

Capital Expenditures

Quarter	CapEx
Q3 16	$0
Q2 23	$3M
Q4 23	$16.0K
Q3 24	$1M
Q3 25	$0
Q4 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 25	—	+187.3%
Q4 25	+198.5%	+51.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 16	$548.0K	—
Q2 23	$0	0.0%
Q4 23	$641.0K	21.2%
Q3 24	$0	0.0%
Q3 25	$476.0K	14.8%
Q4 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	SG&A
Q3 16	$2M	—
Q3 24	—	$2M
Q3 25	—	$1M
Q4 25	—	$2M

Revenue Segments

Quarter	Administration and Service Fees	Management Service, Base	Property Management Fees	Project Management Fees	Real Estate Rental Income
Q2 23	$220.0K	$1M	$278.0K	—	—
Q3 24	$362.0K	$2M	$300.0K	—	—
Q3 25	$424.0K	$2M	$307.0K	$365.0K	$136.0K
Q4 25	$431.0K	$4M	$332.0K	$426.0K	$138.0K

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$23M	$31M	$53M
Q4 22	$22M	$50M	$72M
Q1 23	$23M	$41M	$64M
Q2 23	$19M	$55M	$74M
Q3 23	$84M	$35M	$119M
Q4 23	$60M	$57M	$117M
Q1 24	$41M	$73M	$114M
Q2 24	$49M	$74M	$123M
Q3 24	$49M	$72M	$121M
Q4 24	$51M	$66M	$117M
Q1 25	$46M	$67M	$113M
Q2 25	$47M	$62M	$109M
Q3 25	$35M	$59M	$94M
Q4 25	$35M	$75M	$109M
Q1 26	$59M	$67M	$126M
Q2 26	$58M	$48M	$105M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 16	9M	—	—
Q2 23	29M	+205.0%	—
Q4 23	30M	+2.7%	—
Q3 24	30M	+1.8%	—
Q3 25	27M	-10.5%	+185.4%
Q4 25	38M	+40.2%	+31.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 16	—	—
Q2 23	$4.9K	381
Q4 23	$126.1K	24
Q3 24	$116.1K	24
Q3 25	$103.5K	31
Q4 25	$112.2K	50

Revenue / Employee